Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole PR/XR Monotherapy in Parkinson's Disease
NCT00434304Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ropinirole in Parkinson's disease (PD), sponsored by GSK. Started Apr 2007; status: completed.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00434304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434304.